| ACORAMIDIS 
| ACORAMIDIS | ATC C01EB25
CARDIOVASCULAR TRANSTHYRETIN STABILIZER TREATMENT OF THE CARDIOMYOPATHY OF WILD-TYPE OR VARIANT TRANSTHYRETIN-MEDIATED AMYLOIDOSIS (ATTR-CM) ACORAMIDIS BINDS TTR AT THYROXINE BINDING SITES AND SLOWS DISSOCIATION OF THE TTR TETRAMER | ORAL | Cmax 46.8 MICROMOLAR Tmax 1 HOUR VD 654 LITER PPB 96 PERCENT Cl 16 LITER / HOUR HT 6 HOUR SOLUBILITY 12 MICROGRAM PER MILLILITER | TRANSTHYRETIN (TTR) PDB 4HIQ (THE STRUCTURE OF V122I MUTANT TRANSTHYRETIN IN COMPLEX WITH AG10) LIGAND CODE = 16V (link to the list of PDB complexes) Download experimental 3D coordinates of 16V with added hydrogens | - more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com VigiAccess SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |